3
Announcements
Trials
Browse
Landscape
Phase
Phase 2
1
Status
Completed
1
Active not recruiting
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Other solid neoplasm
1
Conditions
Breast Neoplasms
9
Endometrial Neoplasms
4
Carcinoma, Renal Cell
4
Neuroendocrine Tumors
3
Tuberous Sclerosis
2
Recurrence
2
Neoplasm Metastasis
2
Kidney Neoplasms
2
Thyroid cancer, Hurthle cell
1
Thyroid Neoplasms
1
Thyroid Diseases
1
Solid Tumor
1
Seizures
1
Sarcoma
1
Primary Non-metastatic Breast Cancer
1
Precursor Cell Lymphoblastic Leukemia-Lymphoma
1
Myelodysplastic Syndromes
1
Multiple Endocrine Neoplasia Type 1
1
Liposarcoma
1
Leukemia, Myeloid, Acute
1
Leiomyosarcoma
1
Gastro-enteropancreatic neuroendocrine tumor
1
Endometrial Hyperplasia
1
Clear-cell metastatic renal cell carcinoma
1
Breast Neoplasms, Male
1
Angiomyolipoma
1
Advanced Solid Tumors
1
Advanced Cancer
1
Interventions
pembrolizumab
3
zimberelimab
1
tilsotolimod
1
sintilimab
1
sacituzumab govitecan
1
niraparib
1
encorafenib
1
cobimetinib
1
cedazuridine
1
binimetinib
1
atezolizumab
1
Radiosurgery
1
Proton Therapy
1
Nivolumab
1
Ipilimumab
1
Everolimus
1
Decitabine
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Active not recruiting
×
Solid Tumor
×
Everolimus
×
Clear all
NCT04185831
2024-08-22
MEGALiT
Uppsala University Hospital
Phase 2
Active not recruiting
167 enrolled